A randomized trial of high-versus conventional-dose cytarabine in consolidation chemotherapy for adult de novo acute myeloid leukemia in first remission after induction therapy containing high-dose cytarabine.
about
Progress in acute myeloid leukemiaClostridium difficile Infections amongst Patients with Haematological Malignancies: A Data Linkage StudyLate relapses in acute myeloid leukemia: analysis of characteristics and outcomeHigh-dose cytarabine in acute myeloid leukemia treatment: a systematic review and meta-analysis.The caspase-8 inhibitor emricasan combines with the SMAC mimetic birinapant to induce necroptosis and treat acute myeloid leukemia.Acute myeloblastic leukaemias in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Clofarabine for the treatment of adult acute myeloid leukemia.Retrospective comparison of fludarabine in combination with intermediate-dose cytarabine versus high-dose cytarabine as consolidation therapies for acute myeloid leukemia.Bone Marrow and Peripheral Blood AML Cells Are Highly Sensitive to CNDAC, the Active Form of SapacitabineTimed-sequential chemotherapy as induction and/or consolidation regimen for younger adults with acute myelogenous leukemia.Therapy of core binding factor acute myeloid leukemia: incremental improvements toward better long-term results.Design issues in a randomized controlled trial of a pre-emptive versus empiric antifungal strategy for invasive aspergillosis in patients with high-risk hematologic malignancies.High-dose cytarabine (24 g/m2) in combination with idarubicin (HiDAC-3) results in high first-cycle response with limited gastrointestinal toxicity in adult acute myeloid leukaemia.Leukaemias into the 21st century: part 1: the acute leukaemias.Optimal therapy for adult patients with acute myeloid leukemia in first complete remission.Guidelines on the treatment of acute myeloid leukemia: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular: Project guidelines: Associação Médica Brasileira - 2015.Consensus guidelines for 'rainy day' autologous stem cell harvests in New South Wales.Efficacy and safety of different doses of cytarabine in consolidation therapy for adult acute myeloid leukemia patients: a network meta-analysis.Utility of a clinical risk score to identify high-risk patients with de novo acute myeloid leukaemia in first remission after high-dose cytarabine (HiDAC) based induction chemotherapy.Outcome of high-dose cytarabine-based induction therapy followed by hematopoietic stem cell transplantation in acute myeloid leukemia: influence of karyotype.Can the influence of karyotype in acute myeloid leukemia be overcome by high-dose chemotherapy?IMiDs mobilize acute myeloid leukemia blasts to peripheral blood through downregulation of CXCR4 but fail to potentiate AraC/Idarubicin activity in preclinical models of non del5q/5q- AMLDissecting causes for improved survival among patients with acute myeloid leukemia in two different eras receiving identical regimens in sequential randomized studies
P2860
Q27024006-85E98EB9-018D-4160-9784-1EE174B30EA0Q31108764-2A03A034-0FE8-4F1F-A2FE-2C3BD3AAB650Q33861781-F2402572-C7D0-474E-898F-2E6EA2F21ED3Q34317679-EFFCDD8E-180E-4CB3-99E0-1506519B0CA4Q34527239-C01C3F30-9D19-4B5E-B36F-6280FE6348B4Q34655572-A11424A7-79BD-4B3A-84FA-B17A40D6D5D7Q35009273-17ED4C21-707A-4574-A912-9AB00813CE98Q36152664-4C082DE0-00DD-47EE-9381-15C677291253Q36289307-1E9F5736-8951-4821-BBEC-A65277AA9D80Q36761725-4D6A7CDC-9F1D-4885-9CD4-27C7145F7B3AQ37372832-EFD52069-7EB4-4979-A2FC-97E947630CDDQ37833638-FCC100D9-4289-4B45-A733-75B95FFB76FBQ38023520-C70EB941-91B3-4F5F-9DD7-8155A087E591Q38060223-ABD6229F-96BF-4E37-AF98-0994CAA82651Q38208953-751E4431-7DA8-4688-A2E2-0E878F274DDAQ38916984-BAA20830-E9F0-46BA-BD5E-A77837058660Q40107848-9EB7163E-9C98-4376-86AA-B0E59EC8D413Q41530049-2332F2A3-F240-4C95-A9FD-3AABC191701FQ43798520-F5AF54BE-9123-46A1-AC02-45E63496BE21Q46216906-4BD4F376-2AC3-42E0-BFD5-E28E96E59AE7Q54703610-7D8D2DAB-C704-497A-8C28-2BA78DCC5EBCQ57927278-FA62419F-1945-4BDB-84E1-B9D7783AD1B1Q58718483-1391727B-8F8F-4AA1-A0D6-99BB700688AF
P2860
A randomized trial of high-versus conventional-dose cytarabine in consolidation chemotherapy for adult de novo acute myeloid leukemia in first remission after induction therapy containing high-dose cytarabine.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
A randomized trial of high-ver ...... ntaining high-dose cytarabine.
@en
A randomized trial of high-ver ...... ntaining high-dose cytarabine.
@nl
type
label
A randomized trial of high-ver ...... ntaining high-dose cytarabine.
@en
A randomized trial of high-ver ...... ntaining high-dose cytarabine.
@nl
prefLabel
A randomized trial of high-ver ...... ntaining high-dose cytarabine.
@en
A randomized trial of high-ver ...... ntaining high-dose cytarabine.
@nl
P2093
P1433
P1476
A randomized trial of high-ver ...... ntaining high-dose cytarabine.
@en
P2093
Anne Gillett
Anthony P Schwarer
Australasian Leukaemia and Lymphoma Group
Christopher Arthur
Devinder Gill
Douglas Joshua
Graham A R Young
Heather Baxter
Jane P Matthews
P304
P356
10.1182/BLOOD-2004-01-0326
P407
P50
P577
2004-06-22T00:00:00Z